These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38825584)

  • 1. Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre study.
    Deng R; Chen X; Zheng D; Xiao Y; Dong B; Cao C; Ma L; Tong Z; Zhu M; Liu Z; Lu S; Fu M; Jin Y; Yin B; Li F; Li X; Abliz P; Liu H; Zhang Y; Yu N; Wu W; Xiong X; Zeng J; Huang H; Jiang Y; Chen G; Pan W; Sang H; Wang Y; Guo Y; Shi D; Yang J; Ran Y; Hu J; Yang L; Bai S; Yu J; Wang X; Li R
    Mycoses; 2024 Jun; 67(6):e13751. PubMed ID: 38825584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tinea capitis: two years experience in a paediatric hospital of Buenos Aires, Argentina].
    Santos PE; Córdoba S; Rodero LL; Carrillo-Muñoz AJ; Lopardo HA
    Rev Iberoam Micol; 2010 Jun; 27(2):104-6. PubMed ID: 20346290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-aminolevulinic acid-photodynamic therapy as a potential approach for kerion.
    Zhang F; Wang S; Li D; Feng Y; Fu H; Li J; Yan H; Shi D
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102855. PubMed ID: 35395413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kerion: an angry tinea capitis.
    John AM; Schwartz RA; Janniger CK
    Int J Dermatol; 2018 Jan; 57(1):3-9. PubMed ID: 27696388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases.
    Zhou X; Liu W; Yang S; Wu A; Chen P; Yin S; de Hoog S; Li M; Feng P
    Mycoses; 2023 Apr; 66(4):338-345. PubMed ID: 36564975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epidemiology of Tinea Capitis in Guangxi Province, China.
    Zheng D; Liang T; Wu W; Al-Odaini N; Pan K; Huang L; Huang G; Tang L; Li X; He S; Jian H; Wei N; Wei LJ; Pan Y; Tang P; Meng C; Qin J; Wan Z; Chen X; Cao C
    Mycopathologia; 2023 Oct; 188(5):489-496. PubMed ID: 37356056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole in the treatment of tinea capitis in children. Case reports with long-term follow-up evaluation. Review of the literature.
    Schauder S
    Mycoses; 2002 Feb; 45(1-2):1-9. PubMed ID: 11856429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort.
    Ginter-Hanselmayer G; Smolle J; Gupta A
    Pediatr Dermatol; 2004; 21(4):499-502. PubMed ID: 15283801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinea capitis in early infancy treated with itraconazole: a pilot study.
    Binder B; Richtig E; Weger W; Ginter-Hanselmayer G
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1161-3. PubMed ID: 19453785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kerion Celsi caused by Microsporum gypseum in a Chinese child, a case report.
    Wei S; Wang H; Li A; Yuan C
    Medicine (Baltimore); 2022 Apr; 101(13):e28936. PubMed ID: 35421059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective two-centre study on prepubertal children with Tinea capitis in Korea.
    Lee WJ; Lee EH; Bang YJ; Jun JB
    Mycoses; 2020 Jan; 63(1):52-57. PubMed ID: 31596519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis.
    Gupta AK; Ginter G
    Pediatr Dermatol; 2001; 18(6):519-22. PubMed ID: 11841643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tinea capitis caused by Microsporum ferrugineum with itraconazole.
    Wisuthsarewong W; Chaiprasert A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S72-9. PubMed ID: 16856430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tinea capitis by Microsporum gypseum, an infrequent species].
    García-Agudo L; Espinosa-Ruiz JJ
    Arch Argent Pediatr; 2018 Apr; 116(2):e296-e299. PubMed ID: 29557619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.